Royal Dutch Shell will cut in half its crude processing capacity and jobs at its Singapore oil refinery as part of efforts to reduce its carbon dioxide (CO2) emissions to net-zero by 2050.
The refinery on Pulau Bukoml island can process 500,000 barrels per oil and is the company's largest wholly-owned refinery.
Shell is restructuring its operations by reducing its oil and gas business and expanding its renewable energy and power division.
According to Shell, Bukom will transition from a crude-oil, fuel-based product slate toward new low-carbon value chains. Consequently, it needs to modify its refinery configuration over the next three years.
Shell is studying products that would be viable following its transition, such as biofuels and bitumen, and use different raw materials or feedstocks, such as recycled chemicals.
The plant at Bukom produces 800,000 tons of ethylene a year.
The company will also cut 500 jobs from manpower of 1,300 at Bukom by the end of 2023.
In September, Shell announced globally cutting 9,000 jobs or over 10 percent of its workforce.
It is also reducing the number of oil refining and petrochemical sites from 14 to six, which includes Pulau Bukom, Louisiana, Texas, Canada, Germany, and the Netherlands.


Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Washington Post Publisher Will Lewis Steps Down After Layoffs
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Anta Sports Expands Global Footprint With Strategic Puma Stake
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 



